Literature DB >> 8556565

Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis.

C Svensson1, M Andersson, L Greiff, U Alkner, C G Persson.   

Abstract

BACKGROUND: Mucosal exudation of plasma is a non-injurious, physiological response of the airway microcirculation to different inflammatory processes. The exudative response is similar in the nose and bronchi and exudation occurs in both allergic asthma and rhinitis. The exudative response is a specific end-organ function of the mucosal microcirculation that may be altered in airway diseases.
OBJECTIVE: This study examines the hypothesis of altered responsiveness of the superficial airway microcirculation to vascular permeability-increasing challenges in sustained allergic inflammation.
METHODS: Fourteen patients with birch-pollen induced allergic rhinitis were studied for 7 weeks during a Swedish birch-pollen season. Nasal symptoms (itching, sneezing, blockage, and discharge) were recorded and the occurrence of pollen was determined. The plasma exudation response was examined by topical histamine challenges at the end (May) and well out of (December) the season. Challenge and lavage were carried out concomitantly using a 'nasal pool'-device. The unilateral nasal cavity was filled for consecutive 10 minute periods with saline and two concentrations of histamine (80 micrograms/mL and 400 micrograms/mL). The lavage fluid levels of different-sized plasma proteins (albumin-66,000 D, fibrinogen-340,000 D, and alpha 2-macroglobulin-725,000 D) were determined.
RESULTS: The pollen season was mild resulting in only minor nasal symptoms. Histamine produced exudation of all plasma proteins across the microvascular epithelial barriers with particularly strong correlation between the levels of albumin and alpha 2-macroglobulin (r = 0.98; P < 0.001). The exudative response to histamine was concentration-dependent (P < 0.05) and, furthermore, it was significantly greater late into the season compared with outside the pollen season (albumin: P < 0.05, fibrinogen; P < 0.05, alpha 2-macroglobulin: P < 0.01).
CONCLUSION: We conclude that histamine produced concentration-dependent nasal airway exudation of bulk plasma in subjects with seasonal rhinitis and that this response is abnormally great during the pollen season. Whether angiogenesis or increased responsiveness of the microvascular endothelium may explain this phenomenon now remains unknown. We suggest that a microvascular exudative hyperresponsiveness may characterize allergic airway disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556565      PMCID: PMC7188352          DOI: 10.1111/j.1365-2222.1995.tb00396.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  28 in total

1.  Seasonal increase of bronchial reactivity in allergic rhinitis.

Authors:  E Madonini; G Briatico-Vangosa; A Pappacoda; G Maccagni; A Cardani; F Saporiti
Journal:  J Allergy Clin Immunol       Date:  1987-02       Impact factor: 10.793

Review 2.  Interactions between cytokines and alpha 2-macroglobulin.

Authors:  K James
Journal:  Immunol Today       Date:  1990-05

3.  The nasal response to histamine challenge: effect of the pollen season and immunotherapy.

Authors:  A M Majchel; D Proud; L Freidhoff; P S Creticos; P S Norman; R M Naclerio
Journal:  J Allergy Clin Immunol       Date:  1992-07       Impact factor: 10.793

4.  Inflammatory passage of plasma macromolecules into airway wall and lumen.

Authors:  I Erjefält; C G Persson
Journal:  Pulm Pharmacol       Date:  1989

5.  Allergen challenge-induced entry of alpha 2-macroglobulin and tryptase into human nasal and bronchial airways.

Authors:  C Svensson; R Grönneberg; M Andersson; U Alkner; O Andersson; B Billing; H Gilljam; L Greiff; C G Persson
Journal:  J Allergy Clin Immunol       Date:  1995-08       Impact factor: 10.793

6.  The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.

Authors:  L Greiff; U Pipkorn; U Alkner; C G Persson
Journal:  Clin Exp Allergy       Date:  1990-05       Impact factor: 5.018

Review 7.  Plasma exudation in the airways: mechanisms and function.

Authors:  C G Persson
Journal:  Eur Respir J       Date:  1991-11       Impact factor: 16.671

8.  The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions.

Authors:  G D Raphael; S D Meredith; J N Baraniuk; H M Druce; S M Banks; M A Kaliner
Journal:  Am Rev Respir Dis       Date:  1989-03

9.  Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.

Authors:  L Greiff; M Andersson; A Akerlund; P Wollmer; C Svensson; U Alkner; C G Persson
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

10.  Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma.

Authors:  J Corren; A D Adinoff; A D Buchmeier; C G Irvin
Journal:  J Allergy Clin Immunol       Date:  1992-08       Impact factor: 10.793

View more
  9 in total

1.  Effects of inhaled histamine, methacholine and capsaicin on sputum levels of alpha 2-macroglobulin.

Authors:  H Halldorsdottir; L Greiff; P Wollmer; M Andersson; C Svensson; U Alkner; C G Persson
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

2.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

3.  Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.

Authors:  L Greiff; M Andersson; C Svensson; M Linden; P Wollmer; C G Persson
Journal:  Thorax       Date:  1999-01       Impact factor: 9.139

4.  Biological effects and clinical efficacy of a topical Toll-like receptor 7 agonist in seasonal allergic rhinitis: a parallel group controlled phase IIa study.

Authors:  Lennart Greiff; Cecilia Ahlström-Emanuelsson; Mikaela Alenäs; Gun Almqvist; Morgan Andersson; Anders Cervin; Jan Dolata; Sam Lindgren; Anders Mårtensson; Barbara Young; Henrik Widegren
Journal:  Inflamm Res       Date:  2015-09-05       Impact factor: 4.575

Review 5.  Mechanisms of allergic rhinitis.

Authors:  J N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

6.  Inflammatory patterns of allergic and nonallergic rhinitis.

Authors:  S E Sobol; P Christodoulopoulos; Q A Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

7.  Psoriasin, one of several new proteins identified in nasal lavage fluid from allergic and non-allergic individuals using 2-dimensional gel electrophoresis and mass spectrometry.

Authors:  Malin Bryborn; Mikael Adner; Lars-Olaf Cardell
Journal:  Respir Res       Date:  2005-10-19

Review 8.  Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.

Authors:  Carl Persson
Journal:  J Allergy Clin Immunol       Date:  2018-08-29       Impact factor: 10.793

9.  Inhibition of angiogenic factor production from murine mast cells by an antiallergic agent (epinastine hydrochloride) in vitro.

Authors:  K Asano; A Furuta; K Kanai; S Sakaue; H Suzaki; T Hisamitsu
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.